Lv5
1430 积分 2024-04-25 加入
Cyclin D-CDK4/6 functions in cancer
18小时前
待确认
Trispecific antibodies in cancer therapy: Mechanisms, clinical progress and future directions
4天前
已完结
Trispecific antibodies offer a third way forward for anticancer immunotherapy
4天前
已完结
Two decades of PARP inhibitor synthetic lethality in cancer
13天前
已完结
Minimal residual disease guided treatment approaches in non-Hodgkin lymphoma—Where we are and where we’re headed
22天前
已完结
Patient characteristics, treatment patterns, and clinical outcomes in HER2-negative early breast cancer by germline BRCA status
2个月前
已完结
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2个月前
已完结
Prospective randomized phase II trial to assess the efficacy and safety of neo-adjuvant olaparib/carboplatin (OC) in comparison to docetaxel/epirubicin/cyclophosphamide (TAC) in patients with early triple-negative breast cancer (TNBC) with homologous recombination deficiency (HRD): Primary results from the ABCSG 45 trial
2个月前
已关闭
Complications of Contralateral Prophylactic Mastectomy: Do They Delay Adjuvant Therapy?
2个月前
已完结
Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis
2个月前
已完结
皖公网安备34019202002308
